Cargando…

Cognitive functioning in mild hyperphenylalaninemia

BACKGROUND: Hyperphenylalaninemia is a hereditary metabolic disorder that causes elevated blood phenylalanine (Phe). Hyperphenylalaninemias are classified as Phenylketonuria PKU (Phe > 6 mg/dL) or mild hyperphenylalaninemia (mHPA) (Phe 2–6 mg/dL). This study examines the cognitive functioning of...

Descripción completa

Detalles Bibliográficos
Autores principales:	de la Parra, Alicia, García, María Ignacia, Waisbren, Susan E., Cornejo, Verónica, Raimann, Erna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471391/ https://www.ncbi.nlm.nih.gov/pubmed/28649547 http://dx.doi.org/10.1016/j.ymgmr.2015.10.009

Ejemplares similares

Treatment adherence during childhood in individuals with phenylketonuria: Early signs of treatment discontinuation
por: García, María Ignacia, et al.
Publicado: (2017)

Mild hyperphenylalaninemia: to treat or not to treat
por: van Spronsen, Francjan J.
Publicado: (2011)

First-year metabolic control guidelines and their impact on future metabolic control and neurocognitive functioning in children with PKU
por: de la Parra, Alicia, et al.
Publicado: (2017)

Micronutrient in hyperphenylalaninemia
por: Crujeiras, Vanesa, et al.
Publicado: (2015)

Body Composition Profile of Young Patients With Phenylketonuria and Mild Hyperphenylalaninemia
por: Doulgeraki, Artemis, et al.
Publicado: (2014)

Long-term cognitive functioning in individuals with tyrosinemia type 1 treated with nitisinone and protein-restricted diet
por: García, María Ignacia, et al.
Publicado: (2017)

Creatine Levels in Patients with Phenylketonuria and Mild Hyperphenylalaninemia: A Pilot Study
por: Verduci, Elvira, et al.
Publicado: (2021)

Mild hyperphenylalaninemia (hpa) presenting as orthostatic tremor: a case report
por: Li, Hua, et al.
Publicado: (2022)

DNAJC12 deficiency: Mild hyperphenylalaninemia and neurological impairment in two siblings
por: Fino, Edoardo, et al.
Publicado: (2023)

The Utility of Genomic Testing for Hyperphenylalaninemia
por: Tendi, Elisabetta Anna, et al.
Publicado: (2022)

Urine Phenylacetylglutamine Determination in Patients with Hyperphenylalaninemia
por: Andrade, Fernando, et al.
Publicado: (2021)

BH(4)-deficient hyperphenylalaninemia in Russia
por: Gundorova, Polina, et al.
Publicado: (2021)

Psychopathological Risk Assessment in Children with Hyperphenylalaninemia
por: Risoleo, Maria Cristina, et al.
Publicado: (2022)

Clinical and Genetic Characteristics of Patients with Mild Hyperphenylalaninemia Identified by Newborn Screening Program in Japan
por: Odagiri, Shino, et al.
Publicado: (2021)

Tetrahydrobiopterin responsiveness in a series of 53 cases of phenylketonuria and hyperphenylalaninemia in Iran
por: Setoodeh, Aria, et al.
Publicado: (2015)

Clinical, genetic, and experimental research of hyperphenylalaninemia
por: Chen, Anqi, et al.
Publicado: (2023)

Prevalence of Neonatal Hyperphenylalaninemia in Yazd Province, Iran
por: Ordooei, Mahtab, et al.
Publicado: (2015)

Anthropometry and bone mineral density in treated and untreated hyperphenylalaninemia
por: Zerjav Tansek, Mojca, et al.
Publicado: (2020)

Behavioral and Neurochemical Characterization of New Mouse Model of Hyperphenylalaninemia
por: Pascucci, Tiziana, et al.
Publicado: (2013)

Two novel mutations in DNAJC12 identified by whole‐exome sequencing in a patient with mild hyperphenylalaninemia
por: Li, Mengting, et al.
Publicado: (2020)

Food Habits and Lifestyle in Hyperphenylalaninemia Patients: Should These Be Monitored?
por: Dicintio, Annamaria, et al.
Publicado: (2022)

Executive functions in preschool children with moderate hyperphenylalaninemia and phenylketonuria: a prospective study
por: Paermentier, Laetitia, et al.
Publicado: (2023)

Neonatal screening and genotype-phenotype correlation of hyperphenylalaninemia in the Chinese population
por: Wang, Xin, et al.
Publicado: (2021)

Incidence of Neonatal Hyperphenylalaninemia in Fars Province, South Iran
por: Karamifar, Hamdollah, et al.
Publicado: (2010)

Examining the blood amino acid status in pretherapeutic patients with hyperphenylalaninemia
por: Liang, Lili, et al.
Publicado: (2019)

Detection of Single-Nucleotide and Copy Number Defects Underlying Hyperphenylalaninemia by Next-Generation Sequencing
por: Tendi, Elisabetta Anna, et al.
Publicado: (2023)

Hyperphenylalaninemias genotyping: Results of over 60 years of history in Lombardy, Italy
por: Rovelli, Valentina, et al.
Publicado: (2022)

Supportive care in a patient with Alstrom syndrome with hyperphenylalaninemia and sleep problems
por: Jalilolghadr, Shabnam, et al.
Publicado: (2023)

Diagnostic and therapeutic recommendations for the treatment of hyperphenylalaninemia in patients 0–4 years of age
por: Muntau, Ania C., et al.
Publicado: (2018)

Telehealth and COVID-19: Empowering Standards of Management for Patients Affected by Phenylketonuria and Hyperphenylalaninemia
por: Rovelli, Valentina, et al.
Publicado: (2021)

Intellectual and Developmental Status in Children With Hyperphenylalaninemia and PKU Who Were Screened in a National Program
por: Aghasi, Parisa, et al.
Publicado: (2015)

Haplotype-based Noninvasive Prenatal Diagnosis of Hyperphenylalaninemia through Targeted Sequencing of Maternal Plasma
por: Ye, Jun, et al.
Publicado: (2018)

Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH(4))-responsiveness in patients with hyperphenylalaninemia
por: Lampret, Barbka Repic, et al.
Publicado: (2022)

Stress Hyperphenylalaninemia Is Associated With Mortality in Cardiac ICU: Clinical Factors, Genetic Variants, and Pteridines*
por: Wang, Chao-Hung, et al.
Publicado: (2022)

A Case of Suspected Hyperphenylalaninemia at Newborn Screening by Tandem Mass Spectrometry during Total Parenteral Nutrition
por: Pieragostino, Damiana, et al.
Publicado: (2020)

Analysis of cognitive ability and adaptive behavior assessment tools used in an observational study of patients with mucopolysaccharidosis II
por: Yee, Karen S., et al.
Publicado: (2021)

Physical Activity and Cognitive Function in Mild Cognitive Impairment
por: Chang, Ya-Ting
Publicado: (2020)

PAH Pathogenic Variants and Clinical Correlations in a Group of Hyperphenylalaninemia Patients from North-Western Romania
por: Iuhas, Alin, et al.
Publicado: (2023)

Computer-based cognitive rehabilitation program GRADIOR for mild dementia and mild cognitive impairment: new features
por: Franco-Martín, Manuel A., et al.
Publicado: (2020)

Benzene Derivatives from Ink Lead to False Positive Results in Neonatal Hyperphenylalaninemia Screening with Ninhydrin Fluorometric Method
por: Feng, Shuren, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cp3bebcojjae3pqjkt0cqshf3q